The findings invite further exploration of glutathione as a valuable asset in the pursuit of radiant and healthy skin
With further optimization of these scaffolds, more selective, potent, and bioavailable DPP-4 inhibitors can be developed [78,81]
The market is shaped by high obesity prevalence-over 100 million adults, coupled with reimbursement complexity across Medicare, Medicaid, and commercial plans [1]
f PPI, proton pump inhibitors
Here are the key trials and regulatory decisions to watch this year
Prior to use, patients need to resuspend the PLGA microparticles containing 2 mg exenatide in 0.65 ml phosphate buffer, which also contains sodium chloride (tonicity adjuster), carboxymethylcellulose sodium (suspending agent) and polysorbate 20 (surfactant) (Table 2) [21]